Latest News and Press Releases

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on...

Blaise is a medtech industry thought leader with over 25 years’ experienceA board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech associationPromotion effective...

Acquisition creates a global leader in out-of-hospital software solutionsAccelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in...

SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global...

SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock...

SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic...

2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE...

SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new...

Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today...

SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on...